• Back To Listing

MISYS plc INTERIM MANAGEMENT STATEMENT

Misys continues to grow, total revenue for the first quarter up 6% 1 Misys plc (FTSE: MSY), the global application software and services company, today (30 September 2008) publishes its Interim Management Statement based upon unaudited financial information for the period ended 31 August 2008. Misys plc interim results are expected to be announced on 29 January 2009. Commenting on trading, Mike Lawrie, Chief Executive, Misys plc, said: “We are pleased with our performance in the year to date and our experience in the first quarter gives us confidence in our performance for the rest of the year, despite the uncertainties prevalent in the current global market. We believe that the productivity improvements, cost savings and other elements of our successful turnaround program, as well as our strength in emerging markets and our limited dependence on any particularly dominant customers, will continue to position Misys well in the marketplace.” “In the first quarter we increased revenues and profits, despite challenging market conditions and the seasonality traditional in our business. On a like for like basis, revenues1 grew 6% and Total Order Intake2 increased 11%. We improved Days Sales Outstanding, especially in our Banking and TCM businesses.” “Banking delivered 9% revenue growth driven by improvement in ILF, with continued growth in Global Services and Maintenance, and Total Order Intake for Banking grew slightly. Treasury & Capital Markets delivered 12% revenue growth driven by continued robust demand for Global Services and strength in Maintenance offsetting a decline in ILF. Total Order Intake for Treasury & Capital Markets increased 14% with growth in both ILF and Global Services.” “In line with our expectations, while our Healthcare total revenues were flat due in part to the pending merger with Allscripts, Healthcare’s Maintenance and Global Services revenues grew and Total Order Intake for Healthcare was up by approximately 16%.” PERFORMANCE UPDATE As previously announced, we have entered into a new agreement with iMedica which allows us to continue to license certain iMedica health and practice management software, marketed under the Misys MyWay brand. We announced that we have obtained new financing to replace funds that were to be provided by Lehman Brothers and now all of the consideration for the merger of Misys Healthcare with Allscripts Healthcare Solutions, Inc. is available. We postponed the Extraordinary General Meeting to vote on this merger until 6 October 2008 and subject to shareholder approval we expect that this transaction will close shortly thereafter once all closing conditions have been satisfied. As announced in July during our fiscal year results, Misys developed several processes and procedures to improve cash collections. In the past quarter, we instituted these programs within our Banking and TCM businesses and during the period, collections in Banking and TCM were £64m, strongly ahead of £45m in Q1 2007/8. In Banking and TCM, Days Sales Outstanding (including unbilled accrued income) improved by 17 days using a rolling 365-day basis3 from 31 May 2008, and Days Sales Outstanding for the Group improved by 9 days from 31 May 2008. The Company had approximately £16m of net debt as of 31 August 2008 due to the seasonality of our cash flows. The Company had approximately £26m of net cash on 31 May 2008. Further information on the results for the period under review both on an ‘as reported’ and like-for-like basis is contained in the Notes to this trading statement. Unless otherwise stated all figures in the paragraphs below refer to like-for-like data. Total Order Intake is recorded contracts signed during the fiscal quarter. The figures in this trading statement are unaudited and have been prepared in accordance with IFRS. [1]On a like for like basis which is at constant exchange rates for continuing operations, excludes disposals and the incremental benefit of acquisitions. [2] Total Order Intake is presented on a gross basis reflecting contracts signed during the fiscal year. The figures in this trading statement are unaudited and have been prepared in accordance with IFRS [3] Days Sales Outstanding is calculated by dividing accrued income and trade receivables by revenue per day (last twelve months revenue divided by 365) . A conference call for analysts and investors will be held at 8.00am BST today. To access this call please dial +44 (0)1452 569 103. The call will be available for replay from later today for 7 days on +44 (0) 1452 550000; Passcode 66585819#. For further information, please contact: ANALYST / INVESTOR INQUIRIES John Kiernan T: +44 (0) 203 320 5596 M: +001 646 233 9954 Email: john.kiernan@misys.com MEDIA INQUIRIES Carl Gibson T: +44 (0) 203 320 5526 M: +44 (0) 782 523 6473 Email: carl.gibson@misys.com ABOUT MISYS PLC Misys plc (FTSE: MSY.L) provides integrated, comprehensive solutions that deliver significant results to organisations in the financial services and healthcare industries. We maximise value for our customers by combining deep knowledge of their business with our commitment to their success. In Banking and Treasury & Capital Markets, Misys is a market leader, with over 1,200 customers, including all of the world’s top 50 banks. In Healthcare, Misys is a market leader, serving more than 110,000 physicians in 18,000 practice locations and 600 home care providers. Misys employs around 4,500 people who serve customers in more than 120 countries. We aspire to be the world’s best application software and services company, delivering results for the most important industries in the world. Misys: Experience, Solutions, Results ENDS NOTES: All figures below are unaudited and are prepared in accordance with IFRS. The data below have been provided on both an as reported basis and on a like for like basis. In this interim management statement the like for like numbers illustrate the underlying trading performance of the Group in the period under review. The like for like results exclude the results of the businesses disposed of that are classified as discontinued operations and the incremental benefit of acquisitions. Like for like figures are quoted in sterling using average exchange rates for the three month period ended 31 August 2008. Total Order Intake is presented on a gross basis reflecting contracts signed during the fiscal year. As Reported Like for Like GROUP CONTINUING OPERATIONS Q1 07/08 % Q1 08/09 Q1 07/08 % Q1 08/09 £m Change £m £m Change £m Total Order Intake 48 16% 56 50 11% 56 REVENUE Group total 104 9% 114 108 6% 114 Banking 31 13% 35 32 9% 35 Treasury & Capital Markets 27 16% 32 29 12% 32 Healthcare 46 3% 47 47 0% 47 As Reported Like for Like BANKING Q1 07/08 % Q1 08/09 Q1 07/08 % Q1 08/09 £m Change £m £m Change £m Total Revenue 31 13% 35 32 9% 35 Total Order Intake 13 6% 14 14 1% 14 ILF 5 (4%) 5 5 (7%) 5 Global Services 8 13% 9 9 6% 9 Revenue Highlights ILF 5 30% 6 5 28% 6 Maintenance 18 8% 20 19 3% 20 Global Services 8 16% 9 8 12% 9 As Reported Like for Like TCM Q1 07/08 % Q1 08/09 Q1 07/08 % Q1 08/09 £m Change £m £m Change £m Total Revenue 27 16% 32 29 12% 32 Total Order Intake 10 19% 12 10 14% 12 ILF 4 18% 5 4 12% 5 Global Services 6 20% 7 6 15% 7 Revenue Highlights ILF 6 (9%) 6 6 (12%) 6 Maintenance 13 17% 15 14 12% 15 Global Services 5 46% 8 6 41% 8 As Reported Like for Like HEALTHCARE Q1 07/08 % Q1 08/09 Q1 07/08 % Q1 08/09 £m Change £m £m Change £m Total Revenue 46 3% 47 47 0% 47 Total Order Intake 25 19% 30 26 16% 30 ILF 4 (4%) 4 4 (7%) 4 ASP - MyWay - - 3 - - 3 Subtotal 4 73% 7 4 69% 7 Global Services 3 9% 3 3 7% 3 Transaction Processing 16 7% 17 16 4% 17 Revenue Highlights ILF 5 (19%) 4 5 (21%) 4 Maintenance 18 8% 19 18 5% 19 Transaction Processing 18 2% 18 19 (1%) 18 Global Services 3 13% 3 3 10% 3 As Reported Like for Like GLOBAL SERVICES Q1 07/08 % Q1 08/09 Q1 07/08 % Q1 08/09 (included in divisional figures) £m Change £m £m Change £m Total Revenue 16 25% 20 17 21% 20 Banking 8 16% 9 8 12% 9 Treasury & Capital Markets 5 46% 8 6 41% 8 Healthcare 3 13% 3 3 10% 3 Total Order Intake 17 15% 19 18 9% 19 Banking 8 13% 9 9 6% 9 Treasury & Capital Markets 6 20% 7 6 15% 7 Healthcare 3 9% 3 3 7% 3 FOREIGN EXCHANGE The principal foreign exchange rates used by the Group are detailed in the table below: Closing Balance Average for the period At 31 August 2007 2008 2007 2008 US Dollar 2.0166 1.8199 2.0099 1.9547 Euro 1.4782 1.2407 1.4783 1.2630